Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT

Magnetic Resonance in Medicine

Volumn 66, Issue 5, 2011, Pages 1267-1274

  Korporaal, Johannes G ^a   Van Den Berg, Cornelis A T ^a   Van Osch, Matthias J P ^b   Groenendaal, Greetje ^a   Van Vulpen, Marco ^a   Van Der Heide, Uulke A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

arterial input function; dynamic contrast enhanced (DCE) MRI; phase signal; prostate cancer

Indexed keywords

DIAGNOSIS; MAGNETIC RESONANCE IMAGING; UROLOGY;

ACCURATE MEASUREMENT; ARTERIAL INPUT FUNCTION; DYNAMIC CONTRAST ENHANCED MRIS (DCE); LONGITUDINAL STUDY; PHASE SIGNALS; PROSTATE CANCERS; TRANSFER CONSTANT; TREATMENT MONITORING;

DISEASES;

GADOBUTROL; IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DYNAMICS; FEMORAL ARTERY; HUMAN; INTERMETHOD COMPARISON; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; QUANTITATIVE ANALYSIS;

EID: 80054803021     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22905     Document Type: Article

References (50)

1. Buckley DL, Roberts C, Parker GJM, Logue JP, Hutchinson CE,. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 2004; 233: 709-715.
2. van Dorsten FA, van der Graaf M, Engelbrecht MRW, van Leenders GJLH, Verhofstad A, Rijpkema M, de la Rosette JJMCH, Barentsz JO, Heerschap A,. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004; 20: 279-287.
3. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL,. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006; 24: 108-113.
4. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL,. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007; 189: W192-W201.
5. Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ, Veltman J, Huisman HJ, Vos P, de Kaa CAH-V, Witjes JA, Krabbe PFM, Heerschap A, Barentsz JO,. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241: 449-458.
6. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J,. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008; 26: 1071-1080.
7. Kiessling F, Huber PE, Grobholz R, Heilmann M, Meding J, Lichy MP, Fink C, Krix M, Peschke P, Schlemmer H-P,. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy. Invest Radiol 2004; 39: 34-44.
8. Padhani AR, MacVicar AD, Gapinski CJ, Dearnaley DP, Parker GJ, Suckling J, Leach MO, Husband JE,. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. Radiology 2001; 218: 365-374.
9. Franiel T, Lüdemann L, Taupitz M, Böhmer D, Beyersdorff D,. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Radiother Oncol 2009; 93: 241-245.
10. Kershaw L, Logue J, Hutchinson C, Clarke N, Buckley D,. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol 2008; 88: 127-134.
11. van Vulpen M, van den Berg CAT, Moman MR, van der Heide UA,. Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol 2009; 93: 180-184.
12. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M,. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 425-430.
13. Rouvière O, Valette O, Grivolat S, Colin-Pangaud C, Bouvier R, Chapelon JY, Gelet A, Lyonnet D,. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor - correlation with biopsy findings. Urology 2004; 63: 922-927.
14. Moman MR, van den Berg CAT, Kruger AEB, Battermann JJ, Moerland MA, van der Heide UA, van Vulpen M,. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 2010; 76: 741-746.
15. Kershaw LE, Hutchinson CE, Buckley DL,. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009; 29: 641-648.
16. Schabel CM, Parker DL,. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 2008; 53: 2345-2373.
17. de Bazelaire C, Rofsky NM, Duhamel G, Zhang J, Michaelson MD, George D, Alsop DC,. Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol 2006; 16: 2083-2091.
18. Cheng H-LM, Wright GA,. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006; 55: 566-574.
19. Roberts C, Little R, Watson Y, Zhao S, Buckley DL, Parker GJM,. The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. Magn Reson Med 2010; 65: 108-119.
20. Cheng HL,. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging 2007; 25: 1073-1078.
21. Ivancevic MK, Zimine I, Montet X, Hyacinthe J-N, Lazeyras F, Foxall D, Vallée J-P,. Inflow effect correction in fast gradient-echo perfusion imaging. Magn Reson Med 2003; 50: 885-891.
22. Akbudak E, Conturo TE,. Arterial input functions from MR phase imaging. Magn Reson Med 1996; 36: 809-815.
23. Akbudak E, Norberg RE, Conturo TE,. Contrast-agent phase effects: an experimental system for analysis of susceptibility, concentration, and bolus input function kinetics. Magn Reson Med 1997; 38: 990-1002.
24. de Rochefort L, Nguyen T, Brown R, Spincemaille P, Choi G, Weinsaft J, Prince MR, Wang Y,. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys 2008; 35: 5328-5339.
25. Hoffman RE,. Measurement of magnetic susceptibility and calculation of shape factor of NMR samples. J Magn Reson 2006; 178: 237-247.
26. van Osch MJP, Vonken E-JPA, Viergever MA, van der Grond J, Bakker CJG,. Measuring the arterial input function with gradient echo sequences. Magn Reson Med 2003; 49: 1067-1076.
27. Conturo TE, Akbudak E, Kotys MS, Chen ML, Chun SJ, Hsu RM, Sweeney CC, Markham J,. Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J Magn Reson Imaging 2005; 22: 697-703.
28. Cron GO, Wallace JC, Stevens WD, Fortin T, Pappas BA, Wilkins RC, Kelcz F, Santyr GE,. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent. Magn Reson Imaging 2005; 23: 619-627.
29. Kotys MS, Akbudak E, Markham J, Conturo TE,. Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI. J Magn Reson Imaging 2007; 25: 598-611.
30. Bleeker EJW, van Buchem MA, Webb AG, van Osch MJP,. Phase-based arterial input function measurements for dynamic susceptibility contrast MRI. Magn Reson Med 2010; 64: 358-368.
31. Foottit C, Cron GO, Hogan MJ, Nguyen TB, Cameron I,. Determination of the venous output function from MR signal phase: feasibility for quantitative DCE-MRI in human brain. Magn Reson Med 2010; 63: 772-781.
32. Cron GO, Foottit C, Yankeelov TE, Avruch LI, Cameron I,. A comparison of arterial input functions derived from phase and magnitude for quantitative DCE-MRI of the prostate. Proc Intl Soc Mag Reson Med 2009; 17: 2248.
33. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann K-P, Claussen CD, Schick F,. ERRATUM: Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006; 41: 859.
34. Sharma P, Socolow J, Patel S, Pettigrew RI, Oshinski JN,. Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans. J Magn Reson Imaging 2006; 23: 323-330.
35. Henderson E, Milosevic MF, Haider MA, Yeung IWT,. Functional CT imaging of prostate cancer. Phys Med Biol 2003; 48: 3085-3100.
36. Buckley DL, Parker GJM,. Tracer Kinetic Modeling for T1-weighted dynamic contrast-enhanced MRI. In:, Jackson A, Buckley DL, Parker GJM, editors. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Heidelberg, Germany: Springer-Verlag; 2005.
37. Blomley MJ, Dawson P,. Bolus dynamics: theoretical and experimental aspects. Br J Radiol 1997; 70: 351-359.
38. Fram EK, Herfkens RJ, Johnson GA, Glover GH, Karis JP, Shimakawa A, Perkins TG, Pelc NJ,. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987; 5: 201-208.
39. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J,. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994; 31: 567-571.
40. Brookes JA, Redpath TW, Gilbert FJ, Murray AD, Staff RT,. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. J Magn Reson Imaging 1999; 9: 163-171.
41. Korporaal JG, van den Berg CAT, Jeukens CRLPN, Groenendaal G, Moman MR, Luijten P, van Vulpen M, van der Heide UA,. Dynamic Contrast-enhanced CT for Prostate Cancer: Relationship between Image Noise, Voxel Size, and Repeatability. Radiology 2010; 256: 976-984.
42. Bland JM, Altman DG,. Measurement error. BMJ 1996; 313: 744.
43. Köstler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J,. Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 2004; 52: 296-299.
44. Bae KT,. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003; 227: 809-816.
45. Bhagwandien R, Moerland MA, Bakker CJ, Beersma R, Lagendijk JJ,. Numerical analysis of the magnetic field for arbitrary magnetic susceptibility distributions in 3D. Magn Reson Imaging 1994; 12: 101-107.
46. Yang C, Stadler WM, Karczmar GS, Milosevic M, Yeung I, Haider MA,. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med 2010; 63: 1601-1609.
47. Kierkels RGJ, Backes WH, Janssen MHM, Buijsen J, Beets-Tan RGH, Lambin P, Lammering G, Oellers MC, Aerts HJWL,. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer. Int J Radiat Oncol Biol Phys 2010; 77: 400-408.
48. Bains LJ, McGrath DM, Naish JH, Cheung S, Watson Y, Taylor MB, Logue JP, Parker GJM, Waterton JC, Buckley DL,. Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: a preliminary comparison to assess the magnitude of water exchange effects. Magn Reson Med 2010; 64: 595-603.
49. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CS,. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn Reson Med 1999; 42: 467-478.
50. El-Sharkawy AM, Schär M, Bottomley PA, Atalar E,. Monitoring and correcting spatio-temporal variations of the MR scanner's static magnetic field. MAGMA 2006; 19: 223-236.